Health Canada approves Pfizer anti-viral pill for treatment of COVID-19

with No Comments
Provinces will receive shipments on a per-capita basis and will decide who gets priority for the pills while in short supply.

 

(Ryan Tumilty/ The National Post) — Health Canada has approved Pfizer’s drug Paxlovid as the first take-home treatment for COVID-19.

The drug, which is a treatment involving a total of six pills taken daily for five days, has been shown to reduce the risk of hospitalization by almost 90 per cent. The course of treatment includes two pills of nirmatrelvir taken twice a day and one pill of ​​ritonavir taken twice a day.

The drug prevents the virus from replicating, which helps people recover faster. It can’t be taken by people under 18 years of age. There are also several drugs that can’t be taken alongside Paxlovid, including drugs for cancer, high blood pressure and some anti-anxiety and depression medications. (…)

read full story